loading page

Evaluation of implementation of the primary, secondary and tertiary prevention measures of the Surveillance Program of Gestational and Congenital Toxoplasmosis in the city of Londrina-PR
  • +8
  • Aline Paschoal,
  • Juliana Bernardes,
  • Andre Nadal,
  • Juliana Boas,
  • Ana Silva,
  • Thais Cabral,
  • Eloiza Caldart,
  • Fernanda Pinto-Ferreira,
  • Jaqueline Capobiango,
  • Italmar Navarro,
  • Regina Mitsuka-Breganó
Aline Paschoal
Universidade Estadual de Londrina
Author Profile
Juliana Bernardes
Author Profile
Andre Nadal
Author Profile
Juliana Boas
Author Profile
Thais Cabral
Author Profile
Eloiza Caldart
Author Profile
Fernanda Pinto-Ferreira
Universidade Estadual de Londrina
Author Profile
Jaqueline Capobiango
Author Profile
Italmar Navarro
Universidade Estadual de Londrina
Author Profile
Regina Mitsuka-Breganó
Author Profile

Abstract

Objectives: evaluate the Surveillance Program of Gestational and Congenital Toxoplasmosis. Methods: 424 pregnant women were interviewed regarding their knowledge of prevention measures in 2019. Secondary prevention measures were assessed on the results of anti-Toxoplasma gondii serological tests were collected from pregnant women, from 2015 to 2018. the tertiary prevention measures, we screened the babies of mothers who had recent suspected infections of T. gondii to verify the referrals to the reference service. Results: 45.5% (192/424) reported that they had received guidance from health professionals; 35.4% (68/192) changed their risk habits. The variables of schooling and age, having received prior guidance from health professionals and feline possession, proved to be significant when associated with the notions of preventive measures. 90.2% (17,423 / 19,319) of pregnant women had undergone serological tests to detect anti-T. gondii antibodies but there was an excess in requests for tests and medication and only 40.6% (26/64) of the children were referred to the referral hospital. Conclusions: the Program presents positive results regarding the performance of serological screening in prenatal care; however, the dissemination of knowledge about the prevention of toxoplasmosis and the request for tests need to be improved.

Peer review status:ACCEPTED

22 Jan 2021Submitted to Transboundary and Emerging Diseases
22 Jan 2021Submission Checks Completed
22 Jan 2021Assigned to Editor
27 Jan 2021Reviewer(s) Assigned
24 Mar 2021Review(s) Completed, Editorial Evaluation Pending
27 Mar 2021Editorial Decision: Revise Major
31 Mar 20211st Revision Received
01 Apr 2021Submission Checks Completed
01 Apr 2021Assigned to Editor
01 Apr 2021Reviewer(s) Assigned
11 Apr 2021Review(s) Completed, Editorial Evaluation Pending
13 Apr 2021Editorial Decision: Accept